MarketScreener Strategies Lonza Group AG
Equities
LONN
CH0013841017
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 565.80 CHF | +2.20% |
|
+5.64% | +5.21% |
| 18/12 | Swiss trade surplus at CHF 3.841 bln in November | RE |
| 10/12 | The Berkeley Group Holdings plc Appoints Barbara Richmond as Independent Non-Executive Board Director, Effective 1 January 2026 | CI |
MarketScreener Strategies
Search
No results for this search
Filters
- Stock Market
- Equities
- LONN Stock
- News Lonza Group AG
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















